Elixxer Ltd.
ELIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.23 | -0.00 | 44,549.54 |
| FCF Yield | 0.00% | -4,410.54% | -33.26% | -0.00% |
| EV / EBITDA | 0.00 | 0.00 | -1.20 | -5,837,591.20 |
| Quality | ||||
| ROIC | 0.02% | 0.07% | 0.00% | -14.05% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 96.34% |
| Cash Conversion Ratio | – | 1.00 | 0.29 | 1.10 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | 92.53% | -23.84% |
| Free Cash Flow Growth | 100.00% | 2.60% | -4.55% | -35.59% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | -0.56 | -2.98 |
| Interest Coverage | -0.22 | -0.49 | 0.00 | -1.22 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 244.28 | -352,536.39 |